Do supervised injecting facilities attract higher-risk injection drug users?

American Journal of Preventive Medicine

Volumn 29, Issue 2, 2005, Pages 126-130

  Wood, Evan ^a,b,c   Tyndall, Mark W ^a,b   Li, Kathy ^a   Lloyd Smith, Elisa ^a   Small, Will ^a   Montaner, Julio S G ^a,b   Kerr, Thomas ^a  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; DIAMORPHINE;

ADULT; ARTICLE; CHI SQUARE TEST; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG ABUSE; FEMALE; FOLLOW UP; HUMAN; INFORMATION PROCESSING; INTOXICATION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; QUESTIONNAIRE; RISK ASSESSMENT;

ADULT; BRITISH COLUMBIA; COHORT STUDIES; FEMALE; HUMANS; MALE; NEEDLE-EXCHANGE PROGRAMS; PROGRAM EVALUATION; PROSPECTIVE STUDIES; RISK-TAKING; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 22244468989     PISSN: 07493797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amepre.2005.04.011     Document Type: Article

References (30)

1. S.A. Strathdee, N. Galai, M. Safaeian Sex differences in risk factors for HIV seroconversion among injection drug users a ten-year perspective Arch Intern Med 161 2001 1281 1288
2. D.C. Des Jarlais, H. Hagan, S.R. Friedman, P. Friedmann, D. Goldberg, M. Frischer, S. Green, K. Tunving, B. Ljungberg, A. Wodak Maintaining low HIV seroprevalence in populations of injecting drug users JAMA 274 1995 1226 1231
3. M.W. Tyndall, S. Currie, P. Spittal Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic AIDS 17 2003 887 893
4. J. Garfield, E. Drucker Fatal overdose trends in major US cities 1990-1997 Addict Res Theory 9 2001 425 436
5. E. Wood, M.W. Tyndall, P.M. Spittal Unsafe injection practices in a cohort of injection drug users in Vancouver could safer injecting rooms help? CMAJ 165 2001 405 410
6. P.O. Coffin, S. Galea, J. Ahern, A.C. Leon, D. Vlahov, K. Tardiff Opiates, cocaine, and alcohol combinations in accidental drug overdose deaths in New York City, 1990-98 Addiction 98 2003 739 747
7. D.C. Des Jarlais, N.S. Padian, W. Winkelstein Jr Targeted HIV-prevention programs N Engl J Med 331 1994 1451 1453
8. E. Wood, T. Kerr, J.S. Montaner Rationale for evaluating North America's first medically supervised safer injecting facility Lancet Infect Dis 4 2004 301 306
9. G. Yamey UN condemns Australian plans for "safe injecting rooms." BMJ 320 2000 667
10. J. Kimber, K. Dolan, I. van Beek, D. Hedrich, H. Zurhold Drug consumption facilities an update since 2000 Drug Alcohol Rev 22 2003 227 233
11. K. Dolan, J. Kimber, C. Fry, J. Fitzgerald, D. McDonald, F. Frautmann Drug consumption facilities in Europe and the establishment of supervised injecting centres in Australia Drug Alcohol Rev 19 2000 337 346
12. E. Wood, T. Kerr, P.M. Spittal The potential public health and community impacts of safer injecting facilities evidence from a cohort of injection drug users J AIDS 32 2003 2 8
13. D. Hedrich European report on drug consumption rooms 2004 European Monitoring Centre for Drugs and Drug Addiction Lisbon, Portugal
14. Sydney Medically Supervised Injecting Centre Final report of the evaluation of the Sydney Medically Supervised Injecting Centre 2003 Available at: www.sydneymsic.com/. Accessed May 26, 2005
15. S.A. Strathdee, D.M. Patrick, S.L. Currie Needle exchange is not enough lessons from the Vancouver injecting drug use study AIDS 11 1997 F59 F65
16. S.A. Strathdee, A. Palepu, P.G. Cornelisse Barriers to use of free antiretroviral therapy in injection drug users JAMA 280 1998 547 549
17. E. Wood, T. Kerr, C. Buchner, D.C. Marsh, J.S. Montaner, M. Tyndall Methodology for evaluating Insite Canada's first medically supervised safer injection facility for injection drug users Harm Reduction J 1 2004 9
18. P.M. Spittal, K.J. Craib, E. Wood Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver CMAJ 166 2002 894 899
19. C.L. Miller, E. Wood, P.M. Spittal The future face of coinfection prevalence and incidence of HIV and hepatitis C virus coinfection among young injection drug users J AIDS 36 2004 743 749
20. E. Wod, M.W. Tyndall, P.M. Spittal Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme AIDS 16 2002 941 943
21. T. Corneil, L. Kuyper, J. Shovellor Unstable housing, associated risk behavior, and increased risk for HIV infection among injection drug users Health Place 2005 (in press)
22. M.W. Tyndall, K.J. Craib, S. Currie, K. Li, M.V. O'Shaughnessy, M.T. Schechter Impact of HIV infection on mortality in a cohort of injection drug users J AIDS 28 2001 351 357
23. U. Kemmesies Final report the open drug scene and the safe injection room offers in Frankfurt am Main 1999 City of Frankfurt Municipal Department Frankfurt, Germany
24. W. de Jong, U. Wever The professional acceptance of drug use a closer look at drug consumption rooms in the Netherlands, Gemany, and Switzerland Int J Drug Policy 10 1999 99 108
25. E. Wood, T. Kerr, W. Small Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users CMAJ 171 2004 731 734
26. T.H. Kerr, E. Wood, A. Palepu, D. Wilson, M.T. Schechter, M.W. Tyndall Responding to explosive HIV epidemics driven by frequent cocaine injection is there a role for safer injecting facilities? J Drug Issues 33 2003 597 606
27. T. Kerr, A. Palepu Safe injection facilities in Canada is it time? CMAJ 165 2001 436 437
28. J. Strang, R. Fortson Supervised fixing rooms, supervised injectable maintenance clinics - understanding the difference BMJ 328 2004 102 103
29. N.M. Wright, C.N. Tompkins Supervised injecting centres BMJ 328 2004 100 102
30. D.C. Des Jarlais, D. Paone, J. Milliken Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users a quasi-randomised trial Lancet 353 1999 1657 1661